Tracy H. Krumme

Nuance Communications, Inc. engages in the provision of conversational artificial intelligence (AI) and ambient clinical intelligence services. It offers a wide range of products and services, including clinical documentation, solutions for clinicians, radiologists and care teams, as well as intelligent customer engagement, and security and biometric solutions for brands. It operates through the following segments: Healthcare, Enterprise, Other, and Corporate. The Healthcare segment covers intelligent systems that support a more natural and insightful approach to clinical documentation, freeing clinicians to spend more time caring for patients and helping care teams and health organizations drive meaningful financial and clinical outcomes. The Enterprise segment caters to AAI-powered intelligent customer engagement solutions and service. The Other segment consists of voicemail transcription services. The company was founded in March 1992 and is headquartered in Burlington, MA.

PPD, Inc. engages in the provision of drug development services to the biopharmaceutical industry, focuses on helping customers bring their new medicines to patients around the world. It operates through the Clinical Development Services and Laboratory Services segments. The Clinical Development Services segment focuses in early development/Phase I, patient recruitment and enrollment, investigator site management, Phase II-IV clinical trial management, medical communications and various peri- and post-approval services. The Laboratory Services segment comprises of bioanalytical, vaccine sciences, GMP, central lab and biomarker testing. The company was founded by Fred Eshelma in 1985 and is headquartered in Wilmington, NC.